Barclays’s iKang Healthcare Group, Inc. KANG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-14,909
| Closed | -$304K | – | 7624 |
|
|
2018
Q4 | $304K | Sell |
14,909
-16,523
| -53% | -$294K | ﹤0.01% | 4277 |
|
|
2018
Q3 | $570K | Sell |
31,432
-104,906
| -77% | -$2.02M | ﹤0.01% | 4167 |
|
|
2018
Q2 | $2.79M | Buy |
136,338
+27,106
| +25% | +$547K | ﹤0.01% | 2257 |
|
|
2018
Q1 | $2.18M | Sell |
109,232
-6,945
| -6% | -$117K | ﹤0.01% | 2374 |
|
|
2017
Q4 | $1.83M | Buy |
116,177
+38,048
| +49% | +$550K | ﹤0.01% | 2517 |
|
|
2017
Q3 | $1.05M | Buy |
78,129
+54,539
| +231% | +$730K | ﹤0.01% | 2949 |
|
|
2017
Q2 | $290K | Buy |
23,590
+9,213
| +64% | +$134K | ﹤0.01% | 4047 |
|
|
2017
Q1 | $210K | Buy |
14,377
+14,300
| +18,571% | +$235K | ﹤0.01% | 4270 |
|
|
2016
Q4 | $1K | Hold |
77
| – | – | ﹤0.01% | 6541 |
|
|
2016
Q3 | $1K | Hold |
77
| – | – | ﹤0.01% | 6523 |
|
|
2016
Q2 | $1K | Buy |
+77
| New | +$1.55K | ﹤0.01% | 6227 |
|
|
2016
Q1 | – | Sell |
-194,854
| Closed | -$3.9M | – | 6625 |
|
|
2015
Q4 | $3.9M | Sell |
194,854
-5,146
| -3% | -$88.8K | ﹤0.01% | 1492 |
|
|
2015
Q3 | $2.8M | Buy |
200,000
+160,000
| +400% | +$2.59M | ﹤0.01% | 1832 |
|
|
2015
Q2 | $760K | Buy |
+40,000
| New | +$735K | ﹤0.01% | 3120 |
|
Barclays's KANG Position: Q1 2019 in Review
Barclays sold out of iKang Healthcare Group, Inc. (KANG) in Q1 2019, closing a stake of 14,909 shares — an estimated $304K sold.
Barclays first reported a position in KANG in Q2 2015 and held it in 14 quarters. The position peaked at $3.9M in Q4 2015. 0 funds tracked by Wall St. Rank hold KANG as of Q1 2019.
- Barclays reported no remaining iKang Healthcare Group, Inc. position as of Q1 2019 after selling out during the quarter.
- Barclays sold 14,909 iKang Healthcare Group, Inc. shares in Q1 2019, an estimated $304K.
- Barclays first reported a position in iKang Healthcare Group, Inc. in Q2 2015 and held it in 14 quarters.
- Barclays's iKang Healthcare Group, Inc. position peaked at $3.9M in Q4 2015.
- 0 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q1 2019.
Based on Barclays's 13F filing for Q1 2019, filed 15 May 2019.